Stock FREDUN6 FREDUN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fredun Pharmaceuticals Limited

Equities

FREDUN6

INE194R01017

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:30:53 17/05/2024 pm IST 		5-day change 1st Jan Change
870.4 INR -1.02% Intraday chart for Fredun Pharmaceuticals Limited +4.13% +0.18%
10/05 Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 CI
08/05 Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% MT

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 488.8 1,688 465 1,849 4,057 3,572
Enterprise Value (EV) 1 600.6 1,770 832.3 2,296 4,643 4,403
P/E ratio 27.9 x 36.5 x 24.4 x 91.8 x 64.1 x 32.2 x
Yield 0.42% 0.15% 0.57% 0.15% 0.08% 0.09%
Capitalization / Revenue 0.84 x 1.76 x 0.42 x 1.38 x 1.81 x 1.3 x
EV / Revenue 1.03 x 1.84 x 0.75 x 1.72 x 2.07 x 1.6 x
EV / EBITDA 13.2 x 17.7 x 12.4 x 25 x 33.5 x 15.2 x
EV / FCF -7.95 x -4.8 x -5.62 x -29.1 x -13.8 x -9.81 x
FCF Yield -12.6% -20.8% -17.8% -3.44% -7.27% -10.2%
Price to Book 2.21 x 4.33 x 1.13 x 4.29 x 5.96 x 3.66 x
Nbr of stocks (in thousands) 3,425 3,990 3,990 3,990 4,433 4,595
Reference price 2 142.7 423.1 116.6 463.6 915.3 777.2
Announcement Date 08/09/18 29/08/19 05/09/20 04/09/21 08/09/22 06/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 580.7 961.5 1,109 1,338 2,245 2,747
EBITDA 1 45.62 99.89 67.35 91.94 138.7 288.8
EBIT 1 32.94 86.77 48.69 72.12 117.4 261.1
Operating Margin 5.67% 9.02% 4.39% 5.39% 5.23% 9.51%
Earnings before Tax (EBT) 1 26.42 61.62 24.95 32.07 86 175.1
Net income 1 17.51 44.6 19.02 20.15 63.35 108.1
Net margin 3.02% 4.64% 1.71% 1.51% 2.82% 3.93%
EPS 2 5.112 11.59 4.767 5.050 14.29 24.13
Free Cash Flow 1 -75.51 -368.9 -148.2 -79.01 -337.4 -448.7
FCF margin -13% -38.37% -13.36% -5.9% -15.03% -16.34%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.6000 0.6500 0.6600 0.7000 0.7000 0.7000
Announcement Date 08/09/18 29/08/19 05/09/20 04/09/21 08/09/22 06/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net Debt 1 112 82.2 367 447 586 831
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.451 x 0.8234 x 5.454 x 4.86 x 4.221 x 2.879 x
Free Cash Flow 1 -75.5 -369 -148 -79 -337 -449
ROE (net income / shareholders' equity) 11.9% 14.6% 4.74% 4.77% 11.4% 13.1%
ROA (Net income/ Total Assets) 3.04% 5.89% 2.56% 2.98% 4.21% 7.35%
Assets 1 575.7 757.4 743.9 677.1 1,505 1,471
Book Value Per Share 2 64.70 97.70 104.0 108.0 154.0 213.0
Cash Flow per Share 2 4.240 3.680 6.900 2.490 4.370 6.500
Capex 1 82.1 164 14.9 13.9 42.7 94.9
Capex / Sales 14.14% 17.04% 1.35% 1.04% 1.9% 3.46%
Announcement Date 08/09/18 29/08/19 05/09/20 04/09/21 08/09/22 06/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
FREDUN PHARMACEUTICALS LIMITED Stock Fredun Pharmaceuticals Limited
+0.18% 4.95Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+7.39% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
NOVARTIS AG Stock Novartis AG
+10.02% 21TCr
AMGEN INC. Stock Amgen Inc.
+8.49% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. FREDUN6 Stock
  4. Financials Fredun Pharmaceuticals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW